Income Statement

v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)        
Revenue $ 14,444,957 $ 21,883,445 $ 59,586,148 $ 56,282,542
Cost of Revenue 11,561,834 14,305,698 42,864,857 35,555,746
Gross profit 2,883,123 7,577,747 16,721,291 20,726,796
Operating expenses        
Sales and marketing 1,547,161 2,258,937 5,427,358 5,331,948
Distribution costs 2,291,945 2,352,684 7,516,748 8,010,373
General and administrative expenses 2,399,387 2,602,312 6,685,881 6,807,739
Share-based compensation 212,758 1,146,299 965,229 3,126,472
Amortization of acquired intangible assets 1,062,734 1,124,500 3,188,201 2,709,167
Depreciation 306,185 225,879 901,521 649,883
Total Operating expenses 7,820,170 9,710,611 24,684,938 26,635,582
Loss from operations (4,937,047) (2,132,864) (7,963,647) (5,908,786)
Other income (expense), net        
Change in derivative liability 0 0 0 (1,770)
Interest (expense) income, net 661,878 152,360 2,612,617 2,370,294
Other income (expense), net 661,878 152,360 2,612,617 2,368,524
Income (loss) on operations before income tax (5,598,925) (1,980,504) (10,576,264) (8,277,310)
Gain on sale of Infusionz and select assets 0 0 0 7,564,363
Gain (loss) from the sale of Interactive Offers (103,263) 0 237,670  
Lease settlement, California facility 0 0 0  
Lease impairment, Delray Beach facility 0 0 (289,968)  
Income tax benefit (expense) 1,501,595 496,880 2,668,769 449,828
Net income (loss) from continuing operations (4,200,593) (1,483,624) (7,959,793) (263,119)
(Loss) income from discontinued operations 81,981 (287,119) 46,874 (1,663,451)
Net loss attributable to non-controlling interest 0 124,804 0 358,390
Net income (loss) attributable to Upexi, Inc. $ (4,118,612) $ (1,645,939) $ (7,912,919) $ (1,568,180)
Basic and dilutive loss per share:        
Income (loss) per share from continuing operations $ (0.20) $ (0.08) $ (0.39) $ (0.02)
(Loss) income per share from discontinued operations 0 (0.02) 0.00 (0.10)
Total income (loss) per share $ (0.20) $ (0.09) $ (0.39) $ (0.09)
Basic weighted average shares outstanding 20,723,542 18,015,837 20,423,924 17,418,877
Fully diluted weighted average shares outstanding 20,723,542 18,015,837 20,423,924 17,418,877

Source